This committee is composed of an independent group of prominent investigators from outside the institution who are appointed by the Director with the concurrence of the Executive Committee. The External Advisory Board provides advice to the Director on important policy, research, personnel, and institutional matters. The input of these scientists is vital because it provides a fresh objective viewpoint, which is needed to keep CURE at the forefront, both locally and nationally. The committee meets once a year during the time of the spring research meeting, when the committee members have the opportunity to observe presentations of ongoing research at CURE. When urgent matters arise during the year for which this committee's viewpoint is desirable, as well as for their evaluation and prioritization of Pilot and Feasibility studies, committee member's input is sought either by letter or by phone. The Director and Co-Director are ex officio members of the committee. The chair of the External Advisory Board serves as a vital advocate for CURE with the Dean of the medical school and with the NIH.

Members:

David Alpers, M.D., Chair, Professor of Medicine and Chief, GI Division, Washington University School of Medicine, St. Louis, Missouri

Eugene B. Chang, M.D., Professor, Department of Medicine/GI
University of Chicago, Chicago, IL.

Robert J. Coffey, Jr., M.D., Professor of Medicine and Cell Biology, Vanderbilt University Medical Center, Nashville, Tennessee.

Michael D. Gershon, M.D., Professor and Chair, Department of Anatomy and Cell Biology, Columbia University, New York

Kenneth Wang, M.D. Professor of Medicine, Mayo Clinic

Enrique Rozengurt, DVM, Ph.D. (ex-officio)